NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Collections Health Policy and Services Research Remove constraint Collections: Health Policy and Services Research Languages English Remove constraint Languages: English

Search Results

5051. Oncology pharmaceuticals: reproductive toxicity testing and labeling recommendations

5052. Considerations in demonstrating interchangeability with a reference product

5053. FDA deems certain tobacco products subject to FDA authority, sales and distribution restrictions, and health warning requirements for packages and advertisements: (revised)

5054. Extension of certain tobacco product compliance deadlines related to the final deeming rule: (revised)

5055. Interpretation of and compliance policy for certain label requirement: applicability of certain Federal Food, Drug, and Cosmetic Act requirements to vape shops

5056. Premarket tobacco product applications for electronic nicotine delivery systems

5057. Marketing clearance of diagnostic ultrasound systems and transducers: guidance for industry and Food and Drug Administration staff

5059. Compliance policy for certain compounding of oral oxitriptan (5-HTP) drug products for patients with tetrahydrobiopterin (BH4) deficiency: immediately in effect guidance for industry

5060. Delayed graft function in kidney transplantation: developing drugs for prevention